Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
EClinicalMedicine(2023)
摘要
Bayer/Bristol Myers Squibb.
更多查看译文
关键词
Metastatic colorectal cancer,Microsatellite stable,Mismatch repair-proficient,Nivolumab,Regorafenib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要